Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

Patterns of Depressive Symptoms on Cognitive Function Decline: An Investigation in Middle-Aged Koreans Based on the Korean Longitudinal Study of Aging (KLoSA)

  • Seungyeon Kim (College of Pharmacy, Dankook University)
  • Received : 2024.05.03
  • Accepted : 2024.06.04
  • Published : 2024.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Numerous studies have consistently demonstrated that depression can be associated with cognitive function decline, primarily focusing on older adults due to the neurodegenerative characteristics of dementia. With persistent depression frequently reported in patients with early-onset or young-onset dementia, this study aimed to assess the impact of depression, specifically the changes in depressive symptoms over time, on the risk of cognitive function decline in middle-aged adults in Korea. Methods: This retrospective study utilized data from the first four waves (2006-2012) of the Korean Longitudinal Study of Aging (KLoSA), focusing on middle-aged adults with normal cognitive function at baseline. Changes in depressive symptoms were categorized into four groups based on the CES-D score, and their association with cognitive function decline was evaluated using a multivariate logistic regression model. Results: Of the initial 10,254 participants, 3,400 were included in the analysis. Depressive status, particularly newly onset (adjusted odds ratio [aOR] 1.96; 95% confidence interval [CI] 1.32-2.93) and persistent depression groups (aOR 5.59; 95% CI 2.90-10.78), were significantly associated with cognitive function decline. In contrast, recovery from depressive symptoms was not significantly associated with cognitive function decline (p=0.809). Conclusions: Our study showed a significant association between changes in depressive symptoms and cognitive function decline in middle-aged Korean adults. This suggests that management of depressive symptoms could be crucial for the prevention of cognitive function decline in this population.

Keywords

Acknowledgement

The present research was supported by the research fund of Dankook University in 2022.

References

  1. Hong JW, Noh JH Kim DJ. The prevalence of and factors associated with depressive symptoms in the korean adults: The 2014 and 2016 korea national health and nutrition examination survey. Soc Psychiatry Psychiatr Epidemiol 2021;56(4):659-70. 
  2. Kim GE, Jo MW, Shin YW. Increased prevalence of depression in south korea from 2002 to 2013. Sci Rep 2020;10(1):16979. 
  3. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367(9524):1747-57. 
  4. Jang HY, Song YK, Kim JH, et al. Impact of depression on change in coronary heart disease risk status: The korean genome and epidemiology study (koges). Ther Clin Risk Manag 2018;14:121-8. 
  5. Baek SU, Yoon JH. Depressive symptomatology as a predictor of cognitive impairment: Evidence from the korean longitudinal study of aging (klosa), 2006-2020. Biomedicines 2023;11(10):2713. 
  6. Read JR, Sharpe L, Modini M, Dear BF. Multimorbidity and depression: A systematic review and meta-analysis. J Affect Disord 2017;221:36-46. 
  7. Mast BT, MacNeill SE, Lichtenberg PA. Post-stroke and clinically-defined vascular depression in geriatric rehabilitation patients. Am J Geriatr Psychiatry 2004;12(1):84-92. 
  8. Pariante CM, Lightman SL. The hpa axis in major depression: Classical theories and new developments. Trends Neurosci 2008;31(9):464-8. 
  9. Dafsari FS, Jessen F. Depression-an underrecognized target for prevention of dementia in alzheimer's disease. Transl Psychiatry 2020;10(1):160. 
  10. Kim JH, Kim Y, Kwon J, Park EC. Association between changes in depressive state and cognitive function. Int J Environ Res Public Health 2019;16(24):4944. 
  11. OCED. Elderly Population (Indicator) 2023. Available from https://doi.org/10.1787/8d805ea1-en. Accessed August 16, 2023. 
  12. Bora E, Harrison BJ, Yucel M, Pantelis C. Cognitive impairment in euthymic major depressive disorder: A meta-analysis. Psychol Med 2013;43(10):2017-26. 
  13. Semkovska M, Quinlivan L, O'Grady T, et al. Cognitive function following a major depressive episode: A systematic review and meta-analysis. Lancet Psychiatry 2019;6(10):851-61. 
  14. Snyder HR. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-analysis and review. Psychol Bull 2013;139(1):81-132. 
  15. Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: A systematic review and meta-analysis. Psychol Med 2014;44(10):2029-40. 
  16. Kim D. Effects of depression on changes in cognitive function in older adults: A fixed-effects model analysis using the korean longitudinal study of aging (klosa). Alzheimer Dis Assoc Disord 2022;36(4):319-26. 
  17. Rosness TA, Barca ML, Engedal K. Occurrence of depression and its correlates in early onset dementia patients. Int J Geriatr Psychiatry 2010;25(7):704-11. 
  18. Fatima K, Mehendale AM, Reddy H. Young-onset dementia and neurodegenerative disorders of the young with an emphasis on clinical manifestations. Cureus 2022;14(10):e30025. 
  19. Health Insurance Review & Assessment Service. Analysis of treatment status for depression and anxiety disorders over the last five years (2017-2021) 2022. Available from https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020041000100&brdScnBltNo=4&brdBltNo=10627&pageIndex=1. Accessed September 20, 2023. 
  20. Kim S, Kim Y, Park SM. Body mass index and decline of cognitive function. PLoS One 2016;11(2):e0148908. 
  21. Kim S, Shin S, Yoo H, et al. Impact of weight change on decline of cognitive function among korean adults. Korean J Clin Pharm 2019;29(4):238-46. 
  22. Jang SN, Kawachi I, Chang J, et al. Marital status, gender, and depression: Analysis of the baseline survey of the korean longitudinal study of ageing (klosa). Soc Sci Med 2009;69(11):1608-15. 
  23. Otto E, Culakova E, Meng S, et al. Overview of sankey flow diagrams: Focusing on symptom trajectories in older adults with advanced cancer. J Geriatr Oncol 2022;13(5):742-6. 
  24. Coley N, Giulioli C, Aisen PS, Vellas B, Andrieu S. Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review. Ageing Res Rev 2022;82:101777. 
  25. Zhang Y, Chen SD, Deng YT, et al. Identifying modifiable factors and their joint effect on dementia risk in the uk biobank. Nat Hum Behav 2023;7(7):1185-95. 
  26. Yu JT, Xu W, Tan CC, et al. Evidence-based prevention of alzheimer's disease: Systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg Psychiatry 2020;91(11):1201-9. 
  27. Kessing LV, Sondergard L, Forman JL, Andersen PK. Antidepressants and dementia. J Affect Disord 2009;117(1-2):24-9. 
  28. Mowla A, Mosavinasab M, Pani A. Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial. J Clin Psychopharmacol 2007;27(1):67-70. 
  29. Lee KJ, Lee YJ. Adherence to antidepressants in Korean elderly patients with major depressive disorder. Korean J Clin Pharm 2023;33(1):62-9. 
  30. Keyloun KR, Hansen RN, Hepp Z, Gillard P, Thase ME, Devine EB. Adherence and persistence across antidepressant therapeutic classes: A retrospective claims analysis among insured us patients with major depressive disorder (mdd). CNS Drugs 2017;31(5):421-32. 
  31. Sawada N, Uchida H, Suzuki T, et al. Persistence and compliance to antidepressant treatment in patients with depression: A chart review. BMC Psychiatry 2009;9:38. 
  32. Prukkanone B, Vos T, Burgess P, Chaiyakunapruk N, Bertram M. Adherence to antidepressant therapy for major depressive patients in a psychiatric hospital in thailand. BMC Psychiatry 2010;10:64. 
  33. Readdean KC, Heuer AJ, Scott Parrott J. Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: A systematic review and meta-analysis. Res Social Adm Pharm 2018;14(4):321-31.